Main > A1. CORP. INDEX. L-Lm > Ligand Pharmaceuticals/P C2

---

This data is not available for free

Ligand Pharmaceuticals/P C2's subsections
2002. 05.27.2002. (Diabetes)
2003. 10.20.2003. (Parent of)
2006. 09.07.2006. Onco.>Divestment
2006. 09.07.2006. Pain>Divestment
2008. 09.29.2008. CEO
2009. 10.27.2009. Corp. Acq.
2011. 01.06.2011. Chiva Pharma.
2011. 10.10.2011. Chiva Pharma.
2012. 02.07.2012. VP Corp Dev
2013. 01.09.2013. Retrophin LLC
2013. 07.24. Osteoporosis
2013. 08.14. Topiramate Inj.
2013. 10.03. Menopause>VMS &
2014. 04.23. Onco.>MM
2014. 05.14. Omthera Pharma.
2014. 05.22. Viking Therapeutics
2015. 06.12. cITP>Eltrombopag
2015. 09.02. Severe Aplastic Anemia
2015. 12.17. Acq. OMT Inc
2016. 03.28. Abba Therapeutics
2016. 04.07. cITP>Eltrombopag
2016. 09.16. TeneoBio Inc.
2016. 09.22. Seelos Therapeutics
2018. 12.17. Palvella Therapeutics
2019. 06.12. Onco. Target
2020. 02.11. Icagen Acq Core Assets
2020. 09.10. Acq. 2 Companies
2021. 07.19. Pneumococcal Disease
2021. 08.30. Onco.>cHL
2024. 04.03. Pelthos Therapeutics
Verrow Pharmaceuticals./P C2
Web-Site
Z - OK

Ligand Pharmaceuticals/P C2's products
This section has no products